RSS   Newsletter   Contact   Advertise with us

Medical device suppliers’ merger raises CMA concerns

Christian Fernsby ▼ | July 1, 2020
The Competition and Markets Authority (CMA) is concerned that, should the proposed £4.2 billion purchase by Stryker Corporation of Wright Medical Group N.V. go ahead, it would have a negative impact on vulnerable patients in the UK who need ankle replacements.
Stryker Corporation
Wright Medical Group   Stryker Corporation
Stryker and Wright both manufacture a range of orthopaedic products for patients requiring assistance with their feet, ankles and hands. The total ankle replacement prosthetics produced by Stryker and Wright are predominantly used in elderly orthopaedic patients suffering from arthritis.

Topics: CMA

Following its initial Phase 1 investigation, the CMA found that the proposed merger would result in the merged entity having a share of over 90% in the total ankle replacement prostheses market in the UK.

Should the deal go ahead as planned, the CMA is concerned that Stryker would not face enough competition from other suppliers, leading to higher prices or less choice for hospitals and their patients.